MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,800,500 | +426.2% | 82,000 | +17.8% | 0.55% | +387.6% |
| Q3 2022 | $4,523,000 | +1753.7% | 69,600 | +2312.5% | 0.11% | +1783.3% |
| Q4 2021 | $244,000 | -1.6% | 2,885 | +13.5% | 0.01% | -25.0% |
| Q2 2021 | $248,000 | -13.9% | 2,542 | +3.2% | 0.01% | -27.3% |
| Q1 2021 | $288,000 | +10.3% | 2,464 | +5.1% | 0.01% | +10.0% |
| Q4 2020 | $261,000 | -6.1% | 2,345 | 0.0% | 0.01% | -41.2% |
| Q3 2020 | $278,000 | -87.2% | 2,345 | -87.8% | 0.02% | -88.6% |
| Q2 2020 | $2,178,000 | +39.3% | 19,235 | -17.9% | 0.15% | +14.6% |
| Q1 2020 | $1,564,000 | +11.3% | 23,423 | +51.9% | 0.13% | +6.6% |
| Q4 2019 | $1,405,000 | +60.4% | 15,423 | +51.8% | 0.12% | +52.5% |
| Q3 2019 | $876,000 | -24.3% | 10,157 | -8.0% | 0.08% | -23.8% |
| Q2 2019 | $1,157,000 | -5.8% | 11,039 | +12.6% | 0.10% | -11.8% |
| Q1 2019 | $1,228,000 | – | 9,800 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |